Recap of iRhythm's Q2 2017 earnings call, a discussion on the company's forthcoming Zio AT product, and in partnership with Stanford University scientists, investigating the possibilities of artificial intelligence in ECG monitoring.
Read more
Topics: MobiHealth News
